S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
3 Value Stocks Too Small For Buffett’s Portfolio
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NASDAQ:VERO

Venus Concept (VERO) Stock Price, News & Analysis

$0.69
-0.03 (-4.16%)
(As of 03/28/2024 ET)
Today's Range
$0.68
$0.76
50-Day Range
$0.64
$1.86
52-Week Range
$0.60
$4.70
Volume
36,671 shs
Average Volume
580,698 shs
Market Capitalization
$3.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$33.00

Venus Concept MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
100.0% Downside
$0.00 Price Target
Short Interest
Healthy
0.34% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.68mentions of Venus Concept in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($5.72) to ($2.19) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.49 out of 5 stars

VERO stock logo

About Venus Concept Stock (NASDAQ:VERO)

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.

VERO Stock Price History

VERO Stock News Headlines

Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
Venus Concept (VERO) to Release Earnings on Monday
Venus Concept Launches "NEXThetics" Program
Venus Concept Launches “NEXThetics” Program
Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
Venus Concept Inc VERO
Venus Concept Launches Venus Prime
BTIG Keeps Their Hold Rating on Venus Concept (VERO)
See More Headlines
Receive VERO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Venus Concept and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/27/2023
Today
3/28/2024
Next Earnings (Confirmed)
4/01/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:VERO
Fax
N/A
Employees
384
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$0.00
High Stock Price Target
$0.00
Low Stock Price Target
$10,000,000.00
Potential Upside/Downside
+4,675.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
1 Analysts

Profitability

Net Income
$-43,700,000.00
Pretax Margin
-44.30%

Debt

Sales & Book Value

Annual Sales
$99.50 million
Book Value
$1.77 per share

Miscellaneous

Free Float
2,688,000
Market Cap
$3.82 million
Optionable
Not Optionable
Beta
0.66
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives


VERO Stock Analysis - Frequently Asked Questions

Should I buy or sell Venus Concept stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Venus Concept in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" VERO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in VERO, but not buy additional shares or sell existing shares.
View VERO analyst ratings
or view top-rated stocks.

What is Venus Concept's stock price target for 2024?

1 analysts have issued 1-year price targets for Venus Concept's stock. Their VERO share price targets range from $10,000,000.00 to $0.00. On average, they anticipate the company's stock price to reach $0.00 in the next twelve months. This suggests that the stock has a possible downside of 100.0%.
View analysts price targets for VERO
or view top-rated stocks among Wall Street analysts.

How have VERO shares performed in 2024?

Venus Concept's stock was trading at $1.18 at the beginning of the year. Since then, VERO stock has decreased by 41.4% and is now trading at $0.6910.
View the best growth stocks for 2024 here
.

Are investors shorting Venus Concept?

Venus Concept saw a decrease in short interest during the month of March. As of March 15th, there was short interest totaling 12,900 shares, a decrease of 72.1% from the February 29th total of 46,300 shares. Based on an average daily volume of 536,300 shares, the short-interest ratio is currently 0.0 days. Approximately 0.3% of the shares of the stock are sold short.
View Venus Concept's Short Interest
.

When is Venus Concept's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, April 1st 2024.
View our VERO earnings forecast
.

How can I listen to Venus Concept's earnings call?

Venus Concept will be holding an earnings conference call on Monday, April 1st at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 201-612-7415 with passcode "13744647".

How were Venus Concept's earnings last quarter?

Venus Concept Inc. (NASDAQ:VERO) posted its earnings results on Monday, March, 27th. The company reported ($2.10) EPS for the quarter, hitting analysts' consensus estimates of ($2.10). The business earned $24.29 million during the quarter. Venus Concept had a negative net margin of 43.69% and a negative trailing twelve-month return on equity of 1,279.43%. During the same quarter in the prior year, the firm posted ($1.20) EPS.

When did Venus Concept's stock split?

Venus Concept's stock reverse split on Friday, May 12th 2023. The 1-15 reverse split was announced on Friday, May 12th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 12th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

What other stocks do shareholders of Venus Concept own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Venus Concept investors own include Spectrum Pharmaceuticals (SPPI), CONSOL Energy (CEIX), Salesforce (CRM), Cisco Systems (CSCO), SCYNEXIS (SCYX), AzurRx BioPharma (AZRX), Boeing (BA), Interpace Biosciences (IDXG), Johnson & Johnson (JNJ) and Advanced Micro Devices (AMD).

How do I buy shares of Venus Concept?

Shares of VERO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:VERO) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners